Functional Food Detail
販売休止中
加工食品(錠剤、カプセル剤等)
Category
Notif. Date
2019-04-16
Planned Sale Date
Functional Claim
本品にはラフマ由来ヒペロシド、ラフマ由来イソクエルシトリンが含まれます。ラフマ由来ヒペロシド、ラフマ由来イソクエルシトリンには睡眠の質(眠りの深さ)の向上に役立つことが報告されています。
Content
Functional Claim
本品にはラフマ由来ヒペロシド、ラフマ由来イソクエルシトリンが含まれます。ラフマ由来ヒペロシド、ラフマ由来イソクエルシトリンには睡眠の質(眠りの深さ)の向上に役立つことが報告されています。
AI Summary
Automatically generated from notification documents
This product contains hyperoside and isoquercitrin derived from rhododendron. These ingredients have been reported to improve sleep quality, particularly sleep depth. It is designed to enhance rest quality and support refreshed awakening.
Key Features
[
"
R
h
o
d
o
d
e
n
d
r
o
n
-
d
e
r
i
v
e
d
f
u
n
c
t
i
o
n
a
l
i
n
g
r
e
d
i
e
n
t
s
"
,
"
F
o
c
u
s
e
s
o
n
s
l
e
e
p
d
e
p
t
h
"
,
"
S
u
p
p
o
r
t
s
r
e
s
t
q
u
a
l
i
t
y
"
]
For those seeking improved sleep quality.
Notification Documents
Product Name休眠習慣
Category
Food Classification加工食品(錠剤、カプセル剤等)
Functional Ingredient Nameラフマ由来ヒペロシド、ラフマ由来イソクエルシトリン
Functional ingredient is an extractNo
Functional Claim本品にはラフマ由来ヒペロシド、ラフマ由来イソクエルシトリンが含まれます。ラフマ由来ヒペロシド、ラフマ由来イソクエルシトリンには睡眠の質(眠りの深さ)の向上に役立つことが報告されています。
Consumer Affairs Department Contact
Information Disclosure Website URL
1. Basic Safety Information
(1) Precautions for Intake
(2) Safety Evaluation Method
(3) Notifier's Safety Evaluation
2. Production, Manufacturing & Quality Control
Details
3. Basic Functionality Information
(1) Functionality Evaluation Method
(2) Notifier's Functionality Evaluation
4. Other Notification Items
Reason for not classifying as tablet/capsule food
Primary Target Audience
Planned Sales Start Date
Change History (before Mar 31, 2025)
Change History (from Apr 1, 2025)
Before/After Comparison Table
Before/After Comparison Table (attachments)
If re-notificationNo
Existing Notification Number
Reason for Maintaining Identity
Post-notification Sales Status販売休止中
Reason for Notification Withdrawal
5. Self-Inspection Report
Month of Last Self-Inspection Report